Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sativa Nativa is a Colombian cannabis company focused on research, genetic development, cultivation, processing, and large-scale production of cannabis flower and cannabinoid-derived products. The company presents itself as a pharmaceutical cannabis supplier and operates a large licensed cultivation facility in Santa Marta, Colombia. Its activities appear to span the upstream and intermediate parts of the value chain, including cultivation, derivatives manufacturing, and production inputs for medical and pharmaceutical use rather than a traditional drug-development pipeline. Sativa Nativa was previously a majority-owned subsidiary of Avicanna, but Avicanna sold its stake in June 2022. Available public information indicates the company remains active as a private operating business in Colombia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sativa Nativa.